Search Results for “E_S4HCON2023 Übungsmaterialien – E_S4HCON2023 Lernführung: SAP Certified Technology Specialist – SAP S/4HANA Conversion and SAP System Upgrade – E_S4HCON2023 Lernguide ♿ Suchen Sie auf ⏩ www.itzert.com ⏪ nach 《 E_S4HCON2023 》 und erhalten Sie den kostenlosen Download mühelos 🕑E_S4HCON2023 Online Prüfung” – Page 40

Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA²LEN taskforce position paper

Braido, F.+, Bousquet, P. J., Brzoza, Z., Canonica, G. W., Compalati, E., Fiocchi, A., Fokkens, W., Gerth van Wijk, R., La Grutta, S., Lombardi, C., Maurer, M. Pinto, A. M., Ridolo, E., Senna, G. E., Terreehorst, I., Todo Bom, A., Bousquet, J., Zuberbier, T., and Baiardini, I.: Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA²LEN taskforce position paper. Allergy 2010: 65; 959-968. IF: 6.29

o.099

Looking forward to new targeted treatments for chronic spontaneous urticaria

117.

Kocatürk, E., Maurer, M., Metz, M., and Grattan, C.: Looking forward to new targeted treatments for chronic spontaneous urticaria. Clin. Transl. Allergy 2017: 7; 1-10. IF: 3.54

Kocatürk, E., Maurer, M., Metz, M., and Grattan, C.: Erratum to: Looking forward to new targeted treatments for chronic spontaneous urticaria. Clin. Transl. Allergy 2017: 7; 11

r.117 r.117a

293	Terhorst, D., Koti, I., Krause, K., Metz, M., and Maurer, M.+: In chronic spontaneous urticaria, high numbers of dermal endothelial cells, but not mast cells, are linked to recurrent angioedema. Clin. Exp. Dermatol. 2018: 43; 131-136. IF: 1.77

Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies

216

Bonner, N.+, Abetz-Webb, L., Renault, L., Caballero, T., Longhurst, H., Maurer, M. Christiansen, S., and Zuraw, B.: Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies. Health Qual. Life Outcomes 2015: 13; 92. IF: 2.21

217	Netchiporouk, E., Nguyen, C. H., Thuraisingham, T., Jafarian, F., Maurer, M. and Ben-Shoshan, M.+: Management of pediatric chronic spontaneous and physical urticaria patients with Omalizumab: case series. Pediatr. Allergy Immunol. 2015: 26; 585-588. IF: 3.94

Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema

323

Aygören-Pürsün, E.*+, Bygum, A.*, Grivcheva-Panovska, V., Magerl, M., Graff, J., Steiner, U., Fain, O., Huissoon, A., Kinaciyan, T., Farkas, H., Lleonart, R., Longurst, H., Rae, W., Triggiani, M., Aberer, W., Cancian, M., Zanichelli, A., Smith, W. B., Baeza, M. L., Du-Thanh, A., Gompels, M., Gonzalez-Quevedo, T., Greve, J., Guilarte, M., Katelaris, C., Dobo, S., Cornpropst, M., Clemons, D., Fang, Lei, Collis, P., Sheridan, W., Maurer, M.*, Cicardi, M.*: Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema. New Engl. J. Med. 2018: 379; 352-362. IF: 70.67

252	Krull, C., Schoepke, N., Ohanyan, T., Brachaczek, M., Maurer, M. Lange-Asschenfeldt, B., and Metz, M.+: Increased angiogenesis and VEGF expression correlates with disease severity in prurigo patients. J. Eur. Acad. Dermatol. Venereol. 2016: 30; 1357-1361. IF: 3.52

401.	Maurer, M.⁺, Giménez-Arnau, A., Ensina, L. F., Chu, C.-Y., Jaumont, X, and Tassinari, P.: Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results. World Allergy Organ. J. 2020: 13; 100460. IF: 4.08

o.401

40.	Gimenez-Arnau, A., Maurer, M., de la Cuadra, J., and Maibach, H.: Immediate contact skin reactions, an update of contact urticaria, contact urticaria syndrome and protein contact dermatitis – A never ending story. Eur. J. Dermatol. 2010: 20; 552-562. IF: 2.42

73.	Maurer, M. and Parish, L. C.: The dermatology view of hereditary angioedema: Practical diagnostic and management considerations. J. Eur. Acad. Dermatol. Venereol. 2013: 27; 133-141. IF: 2.78